Patients taking Ramipril 10mg capsules are being urged to check their medication after a batch recall due to packaging errors. The Medicines and Healthcare products Regulatory Agency (MHRA) announced that Crescent Pharma Limited is recalling one batch as a precautionary measure.
What Happened?
The company received a complaint where "inside a sealed carton of Ramipril 10 mg Capsules Batch No.: GR174091, one blister pack of Ramipril 5 mg Capsules Batch No.: GR164094 was found." This means some patients may have received a lower dose than intended.
What Patients Should Do
Healthcare professionals have been instructed to halt supply and quarantine stocks of the affected batch immediately. Patients prescribed Ramipril 10mg who have batch number GR174091 should check their cartons contain the correct medication. The MHRA advises: "If the carton contains blister strips that are labelled and contain Ramipril 5 mg capsule, contact your dispensing pharmacy in the first instance."
Is It Dangerous?
The regulator stressed that both strengths treat high blood pressure, heart failure and kidney disease. Any impact from receiving a lower dose would be gradual rather than immediate or life-threatening. However, those with concerns should seek medical advice and report any adverse reactions via the MHRA Yellow Card scheme.
Patients are reminded that this recall is a precautionary measure, and they should not stop taking their medication without consulting a healthcare professional. If in doubt, contact your pharmacist or GP.
